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Abstract
Axenfeld-Rieger syndrome is a genetic condition characterized by ocular and sys-
temic features and is most commonly caused by variants in the FOXC1 or PITX2
genes. Facial dysmorphism is part of the syndrome but the differences between both
genes have never been systematically assessed. Here, 11 facial traits commonly
reported in Axenfeld-Rieger syndrome were assessed by five clinical geneticists
blinded to the molecular diagnosis. Individuals were drawn from the Australian and
New Zealand Registry of Advanced Glaucoma in Australia or recruited through the
Genetic and Ophthalmology Unit of l'Azienda Socio-Sanitaria Territoriale Grande
Ospedale Metropolitano Niguarda in Italy. Thirty-four individuals from 18 families
were included. FOXC1 variants were present in 64.7% of individuals and PITX2 vari-
ants in 35.3% of individuals. A thin upper lip (55.9%) and a prominent forehead
(41.2%) were common facial features shared between both genes. Hypertelorism/
telecanthus (81.8% vs 25.0%, p = 0.002) and low-set ears (31.8% vs 0.0%, p = 0.036)
were significantly more prevalent in individuals with FOXC1 variants compared with
PITX2 variants. These findings may assist clinicians in reaching correct clinical and
molecular diagnoses, and providing appropriate genetic counseling.
K E YWORD S
Axenfeld-Rieger syndrome, facial dysmorphism, FOXC1, PITX2
1 | INTRODUCTION
Axenfeld-Rieger syndrome (ARS) is an autosomal dominant condition
characterized by ocular and systemic features. Ocular features consist
of the anterior segment dysgenesis spectrum characterized by devel-
opmental abnormalities of the anterior segment of the eye. They
include abnormal angle tissue contributing to a high risk of secondary
glaucoma, hypoplastic iris, additional pupillary opening (pseudopolycoria),
displaced pupil (corectopia), anteriorly displaced Schwalbe's line (poste-
rior embryotoxon), and/or peripheral anterior synechiae (Alward, 2000;
Shields et al., 1985). The most commonly reported systemic features
include facial dysmorphism, dental and umbilical anomalies, cardiac
defects, and hearing impairment (Alward, 2000; Fitch & Kaback, 1978).
Deleterious sequence variants and copy number variation of the FOXC1The authors of this manuscript declare that they have no conflict(s) of interest.
Received: 5 August 2020 Revised: 26 October 2020 Accepted: 31 October 2020
DOI: 10.1002/ajmg.a.61982
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any
medium, provided the original work is properly cited and is not used for commercial purposes.
© 2020 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.
434 Am J Med Genet. 2021;185A:434–439.wileyonlinelibrary.com/journal/ajmga
(6p25.3, MIM 601090) (Mears et al., 1998; Nishimura et al., 1998) and
PITX2 (4q25, MIM 601542) (Semina et al., 1996) genes have been impli-
cated in ARS, as well as another locus (RIEG2 at 13q14) (Phillips
et al., 1996). FOXC1 and PITX2 variants explain ~40% of affected individ-
uals (D'Haene et al., 2011; Reis et al., 2012).
Although the ocular manifestations of the condition associated
with variation of both genes are similar, the systemic features often
vary: individuals with FOXC1 variants are more likely to present with
an isolated ocular phenotype or display a range of systemic features
among which cardiac defects, hearing loss, and growth delay are the
most common. In comparison, PITX2 variants are strongly associated
with the ocular phenotype in combination with dental anomalies
(microdontia, hypodontia) and umbilical defects (periumbilical skin,
umbilical hernia) (D'Haene et al., 2011; Reis et al., 2012; Souzeau
et al., 2017; Strungaru et al., 2007). Minor facial dysmorphism has
been identified as part of the ARS spectrum since the initial reports of
affected individuals, with characteristic facial features including maxil-
lary hypoplasia with flattening of the midface, hypertelorism, a broad
flat nasal root, and a thin upper lip (Alkemade, 1969; Rieger, 1941).
Assessment of dysmorphic features, including facial dysmorphism,
plays a major role in the evaluation of genetic syndromes to reach a
clinical diagnosis. As such, a number of genetic syndromes have well
characterized and recognizable facial features. Although previous stud-
ies have reported on some facial features in cohorts of individuals with
ARS (Reis et al., 2012; Weisschuh et al., 2006), no study has systemati-
cally assessed the prevalence of different facial traits. In this study, we
compared facial dysmorphism between individuals with ARS due to
FOXC1 or PITX2 variants to assess gene-specific differences.
2 | METHODS
2.1 | Subjects
The study was conducted in accordance with the revised Declaration of
Helsinki. Ethics approval was obtained from the Southern Adelaide Clin-
ical Human Research Ethics Committee (Australia), l'Azienda Socio-
Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (Italy)
and the Friedrich-Alexander University of Erlangen-Nuremberg Ethics
Committee (Germany). Individuals were drawn from the Australian and
New Zealand Registry of Advanced Glaucoma (ANZRAG) (Souzeau
et al., 2012) or recruited through the Genetic and Ophthalmology Unit
of l'Azienda Socio-Sanitaria Territoriale Grande Ospedale Metropolitano
Niguarda. Informed consent was obtained from all participants or their
guardians. Ethnicity was self-reported. Individuals with ASD were
tested for variants in the FOXC1 and PITX2 genes by sequencing and
MLPA as previously described (Siggs et al., 2019; Souzeau et al., 2017).
2.2 | Facial dysmorphology
Clinical photographs (frontal and lateral views of the face) of individ-
uals with ARS were obtained at the time of appointment or provided
directly by the participants. The clinical photographs were reviewed
independently by a panel of 5 clinical geneticists experienced in dys-
morphology, blinded to the molecular diagnosis of the participants.
The assessment of the facial traits was subjective and therefore the
presence of the facial traits was considered to be dependent on the
consensus of at least 4 of the 5 geneticists. The presence or absence
of 11 facial traits commonly reported in ARS were recorded for each
participant including: prominent supraorbital ridges, high arched eye-
brows, prominent forehead, hypertelorism, telecanthus, broad flat
nasal bridge, maxillary hypoplasia, protruding lower lip, thin upper lip,
short philtrum and low-set ears. The facial traits were defined
according to the Human Phenotype Ontology (Köhler et al., 2019) and
the Bedside Dysmorphologist (Reardon, 2015) (Table 1). Due to the
subjective nature of the assessment, hypertelorism and telecanthus
were combined together for analysis purposes.
2.3 | Face averaging
Images from individuals with FOXC1 or PITX2 variants were combined
into a single consensus image using the dlib and OpenCV packages in




Greater than average forward and/or lateral




Increased height of the central portion of the




Forward prominence of the entire forehead, due to
protrusion of the frontal bone
Hypertelorism Increased distance between the orbits, where the
inner canthal distance, the outer canthal distance
and interpupillary distance are increased








Abnormally small dimension of the maxilla, usually
creating a malocclusion or malalignment between
the upper and lower teeth or resulting in a
deficient amount of projection of the base of the
nose and lower midface region
Protruding
lower lip
Abnormal configuration of the lower lip such that it
is turned outward (i.e., everted), with the inner
aspect of the lower lip vermilion (normally
opposing the teeth) being visible in a frontal view
Thin upper lip Reduced width of the skin of the vermilion border
region of the upper lip
Short
philtrum
Apparently decreased distance between nasal base
and midline upper lip vermilion border
Low-set ears Upper insertion of the ear to the scalp below an
imaginary horizontal line drawn between the inner
canthi of the eye and extending posteriorly to the
ear
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Python (https://github.com/leoneckert/facemash-workshop). Each
image was subject to facial detection and landmark annotation,
followed by scaling and alignment, with all images for each gene over-
laid to create an “average” face image. Separate consensus images
were generated for each gene for probands only (using the youngest
photograph in each family) and for all individuals.
2.4 | Statistics
PASW Statistics, Rel. 18.0.1.2009 (SPSS Inc., Chicago, IL) was used for
statistical analyses. Data are presented as mean ± SD. Fisher's exact
test was used to assess differences in categorical data. Mann–
Whitney U test and Median test were used to assess differences in
mean and median respectively.
3 | RESULTS
Thirty-four individuals from 18 families were included. The mean age
at recruitment was 29.6 ± 19.5 years and all individuals were Cauca-
sian, apart from one who had a mixed Caucasian/Asian ethnicity
(Individual 5). FOXC1 variants were present in 64.7% (22/34) individ-
uals or 72.2% (13/18) families and PITX2 variants in 35.3% (12/34)
individuals or 27.8% (5/18) families. There were no differences in sex
or age between individuals with FOXC1 vs PITX2 variants (Table 2).
The ocular and systemic features that support the findings of this
study are available in Supplementary Table 1.
The prevalence of the different facial traits in individuals with
FOXC1 or PITX2 variants is summarized in Table 3. The average num-
ber of facial traits for the whole cohort was 2.71 ± 1.40 (range 0–5).
The most common features in the whole cohort seen in over a third
of individuals were telecanthus/hypertelorism, (61.8%), a thin upper
lip (55.9%), and a prominent forehead (41.2%).
Individuals with FOXC1 variants had an average of 2.86 ± 1.52
facial features (range 0–5) compared with 2.42 ± 1.16 (range 0–4) for
individuals with PITX2 variants (p = 0.309). There was no differences
in the number of facial features between individuals who had
sequence variants (n = 2.81 ± 1.41) and those with copy number vari-
ations (n = 2.29 ± 1.38, p = 0.452). The most common traits in FOXC1
were a telecanthus/hypertelorism (81.2%), a thin upper lip (45.5%)
and a prominent forehead (36.4%). In comparison, the most common
traits in PITX2 were a thin upper lip (75.0%), a prominent forehead
(50.0%) and prominent supraorbital ridges (33.3%). Hypertelorism/
telecanthus and low-set ears were significantly more prevalent in indi-
viduals with FOXC1 variants compared with PITX2 variants. Although
not significantly different, a thin upper lip was more common in individ-
uals with PITX2 (75.0%) compared to FOXC1 (45.5%) and maxillary
hypoplasia was only present among individuals with FOXC1 variants
(27.3%). Additionally, geneticists could comment on the presence of
other potential facial traits and the presence of hooded eyelids or ptosis
was suggested in some individuals. However, these traits cannot be for-
merly assessed on clinical photographs and would need to be assessed
in person to investigate potential differences between both groups.
In order to reduce potential bias related to familial facial features
unrelated to the FOXC1 or PITX2 variants, the assessed facial traits were
further analyzed in probands only from 18 families, and was done using
individuals with photographs taken at the youngest age within each fam-
ily. The analysis included 13 individuals with FOXC1 and 5 with PITX2
variants. There were no differences in sex or age between individuals
with FOXC1 vs PITX2 variants (Table 2). Hypertelorism/telecanthus was
still significantly more prevalent in individuals with FOXC1 variants com-
pared with PITX2 variants while low-set ears was not (Table 3).
In order to generate a consensus facial image for each genotype,
face averaging was performed on photographs of individuals with FOXC1
or PITX2 variants (Figure 1). An increased distance between the medial
orbital canthi (telecanthus) was subjectively apparent in average images
of the FOXC1 group, both using all individuals, and in probands alone.
Additionally, we assessed the prevalence of other systemic fea-
tures in individuals with FOXC1 or PITX2 variants (Supplementary
Table 2). Individuals with FOXC1 variants were more likely to have no
other systemic features compared with individuals with PITX2 variants
(p = 0.013). Dental and umbilical anomalies were more prevalent in
individuals with PITX2 variants compared with FOXC1 variants
(p < 0.001) whereas hearing loss was more prevalent in individuals
with FOXC1 variants compared with PITX2 variants (p = 0.036).
4 | DISCUSSION
Facial dysmorphology, as part of a systematic medical examination
and in combination with a complete family history, can assist clinicians
TABLE 2 Demographic details of the entire cohort and probands only
All individuals Probands
Total N (%) FOXC1 N (%) PITX2 N (%) p value Total N (%) FOXC1 N (%) PITX2 N (%) p value
Sex (male) 16/34 (47.1) 11/22 (50.0) 5/12 (41.7) 0.729 11/18 (61.1) 9/13 (69.2) 2/5 (40.0) 0.326
Ethnicity (Caucasian) 33/34 (97.1) 21/22 (95.5) 12/12 (100.0) 1.000 17/18 (94.4) 12/13 (92.3) 5/5 (100.0) 1.000
Age when photographed (years)
Mean 29.6 ± 19.5 27.3 ± 21.6 33.8 ± 14.6 0.231 19.9 ± 18.1 18.3 ± 20.0 24.2 ± 12.4 0.289
Median 32.0 24.5 36.0 0.720 11.5 7.0 22.0 0.294
Range 1-70 1-70 7-56 1-60 1-60 7-39
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in reaching a proper clinical diagnosis. Although the presence of sys-
temic features can facilitate differentiation between FOXC1- or
PITX2-associated ARS (Souzeau et al., 2017), symptoms such as dental
anomalies, hearing loss or growth delay may not manifest before an
older age. Therefore, differences in facial dysmorphism may facilitate
this differentiation prior to molecular testing. To the best of our
knowledge, this is the first study to systematically assess the preva-
lence of facial features in individuals with FOXC1 and PITX2 variants,
including whether there are any significant differences between both
groups of individuals. Early descriptions of individuals with ARS have
reported facial dysmorphism as a common feature (Alkemade, 1969;
Rieger, 1941). However, studies following the identification of the
FOXC1 and PITX2 genes have seldom reported on the facial appear-
ance of affected individuals. Hypertelorism, maxillary hypoplasia and a
broad nasal bridge seem to be the most commonly reported traits in
FOXC1-associated ARS across different populations (D'Haene
et al., 2011; Kawase et al., 2001; Kim et al., 2013; Micheal
et al., 2016; Weisschuh et al., 2006), whereas maxillary hypoplasia
and a thin upper lip are often reported in PITX2-associated ARS
(D'Haene et al., 2011; Reis et al., 2012; Weisschuh et al., 2006). No
study has systematically assessed affected individuals for the pres-
ence or absence of facial traits. In this study, 11 facial traits were
assessed by five clinical geneticists for their presence or absence in a
cohort of 34 individuals with ARS and a molecular diagnosis. Individ-
uals with FOXC1-associated ARS were more likely to have hyper-
telorism/telecanthus and low-set ears compared to individuals with
PITX2-associated ARS. Although not significant, maxillary hypoplasia
was more prevalent in individuals with FOXC1 variants and a thin
upper lip was more prevalent in individuals with PITX2 variants. These
findings are consistent with previous isolated reports of facial
TABLE 3 Prevalence of facial traits in all individuals and probands only with FOXC1 or PITX2 variants
All individuals Probands
Facial trait Total N (%) FOXC1 N (%) PITX2 N (%) p value Total N (%) FOXC1 N (%) PITX2 N (%) p value
Prominent supraorbital ridges 10/34 (29.4) 6/22 (27.3) 4/12 (33.3) 0.714 6/18 (33.3) 5/13 (38.5) 1/5 (20.0) 0.615
High arched eyebrows 4/34 (11.8) 1/22 (4.5) 3/12 (25.0) 0.115 1/18 (5.6) 1/13 (7.7) 0/5 (0.0) 1.000
Prominent forehead 14/34 (41.2) 8/22 (36.4) 6/12 (50.0) 0.487 8/18 (44.4) 5/13 (38.5) 3/5 (60.0) 0.608
Hypertelorism/Telecanthus 21/34 (61.8) 18/22 (81.8) 3/12 (25.0) 0.002 12/18 (66.7) 12/13 (92.3) 0/5 (0.0) 0.001
Broad flat nasal bridge 3/34 (8.8) 3/22 (13.6) 0/12 (0.0) 0.537 2/18 (11.1) 2/13 (15.4) 0/5 (0.0) 1.000
Maxillary hypoplasia 6/34 (17.6) 6/22 (27.3) 0/12 (0.0) 0.069 4/18 (22.2) 4/13 (30.8) 0/5 (0.0) 0.278
Protruding lower lip 3/34 (8.8) 1/22 (4.5) 2/12 (16.7) 0.279 3/18 (16.7) 1/13 (7.7) 2/5 (40.0) 0.172
Thin upper lip 19/34 (55.9) 10/22 (45.5) 9/12 (75.0) 0.152 10/18 (55.6) 6/13 (46.2) 4/5 (80.0) 0.314
Short philtrum 4/34 (11.8) 2/22 (9.1) 2/12 (16.7) 0.602 3/18 (16.7) 2/13 (15.4) 1/5 (20.0) 1.000
Low-set ears 7/34 (20.6) 7/22 (31.8) 0/12 (0.0) 0.036 3/18 (16.7) 3/13 (23.1) 0/5 (0.0) 0.522
Note: Fisher's exact test was used to assess differences between both genes.
F IGURE 1 Face averaging of individuals with FOXC1 or PITX2 variants. (a) Individuals with FOXC1 variants. (b) Individuals with PITX2
variants. The “probands only” images were derived from individuals with photographs taken at the youngest age within each family. M; Male, F;
Female
SOUZEAU ET AL. 437
dysmorphism in FOXC1- or PITX2-associated ARS (D'Haene
et al., 2011; Kawase et al., 2001; Kim et al., 2013; Reis et al., 2012).
Additionally, we analyzed the data including only one individual
per family to account for facial traits that may be common between
members of the same family. This analysis was done using the youn-
gest individual in each family to support clinical diagnosis at the youn-
gest possible age. Hypertelorism/telecanthus remained significantly
more prevalent in individuals with FOXC1 variants compared with
PITX2 variants. The presence of low-set ears was still more common
in individuals with FOXC1 variants but was not significantly different,
potentially due to the smaller size of the cohort.
We previously reported that individuals with FOXC1 variants are
more likely to have no other systemic features than individuals with
PITX2 variants (Souzeau et al., 2017). Dental and umbilical anomalies
are more commonly seen with PITX2 variants whereas hearing loss is
more commonly reported with FOXC1 variants. These findings were
confirmed in this cohort. Although the prevalence of heart defects was
not significantly different between individuals with FOXC1 and PITX2
variants, FOXC1 variants were associated with congenital heart defects
whereas PITX2 variants were associated with arrhythmogenesis. Test-
ing for both genes is often performed for patients with ARS.Neverthe-
less differences in facial dysmorphism or systemic features can guide
the prioritization of gene testing and the analysis of genetic results in
the context of a well-characterized phenotype.
The phenotypic differences in craniofacial morphology that we
observed might be related to the underlying developmental mecha-
nisms regulated by PITX2 and FOXC1. PITX2 protein plays a critical role
in early development of structures in the front part of the eye, as well
as the pituitary cells, teeth, heart, and abdominal organs (Franco
et al., 2014). FOXC1 protein is a transcriptional partner of GLI2 highly
expressed in undifferentiated mesenchyme and is thought to play a reg-
ulator role in chondrogenesis, initiating the ossification of cranial base
bones important for craniofacial morphogenesis (Mya et al., 2018;
Yoshida et al., 2015).
Limitations of this study included a small sample size with the
majority of individuals of European ancestry. Additional studies will be
needed to reproduce these findings in individuals of non-European
ancestry. A subjective assessment of the facial traits was conducted
to mimic the assessment that would be performed by geneticists in a
real life clinic. Each trait was assessed by five experienced geneticists
with consensus to be reached among four of them to address the sub-
jective approach. ARS being a rare condition, we used clinical photo-
graphs to increase the cohort size. However, clinical photographs are
not all to scale, therefore specific measurements for the different
traits were not practicable. Additionally, skull X-rays would be needed
to confirm the presence of hypertelorism which corresponds to an
increased distance between the orbital cavities. Finally, facial traits
change with age in some genetic syndromes and can become more or
less characteristic as the individual grows. Our cohort was too small
to analyze age-related changes and it remains to be seen whether the
facial traits in FOXC1- or PITX2-associated ARS change with age.
In summary, our findings reveal a genotype–phenotype correla-
tion within the spectrum of ARS-associated facial dysmorphism. These
findings have implications for assessing affected individuals to reach
clinical and molecular diagnoses, and for genetic counseling.
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